Training & Supervision
(Professional CEUs provided by Rathbone & Associates)
Committed to providing mental health professionals high quality, state of the art trainings on cutting edge topics to improve clinical outcomes.
Trainings for mental health and other health professionals.
Register for all events here.
Compassion Focused Therapy | 3 Category 1 CEUs*
Racheli Miller, MA and Miranda Morris, PhD
Friday, September 13th, 9:15AM-12:30 PM
4701 Sangamore Road, 210-N, Bethesda, MD 20816
Compassion Focused Therapy (CFT) is a transmodal approach to therapy that draws on concepts from neuroscience, evolutionary psychology, and Buddhist practice to help clients develop fierce compassion for their suffering and the suffering of others. Originally developed for clients with high levels of self-criticism and shame, CFT has demonstrated effectiveness with individuals with a wide range of difficulties, including anxiety disorders, depression, chronic pain, psychosis, eating disorders. and trauma. In this workshop, we will present foundational CFT concepts to help you conceptualize and treat clients from a CFT framework and introduce you to specific CFT interventions and experiential practices that can enhance both your clinical practice and self-practice. Participants will leave this workshop armed with specific CFT techniques and an enhanced understanding of the foundations of CFT.
Through completion of this workshop, participants will learn:
- The CFT definition of compassion in practice.
- To describe and work with the three-circle model of emotion regulation found in CFT.
- The 12 core competencies of compassion, and how they can be conceptualized and developed in psychotherapy.
- Specific compassion-focused interventions (e.g., compassion-focused imagery, the reality check, soothing rhythm breathing) to help clients develop mindfulness, psychological flexibility, and the attributes of compassion.
Racheli Miller, MA (PhD in August) is a predoctoral clinical psychology intern at the Washington DC Veteran Affairs (VA) Medical Center. Before beginning at the VA, she externed at the Center for Compassion Focused Therapy (CFT) in New York City and will be returning there this coming fall as a postdoctoral fellow. During graduate school, she trained in second and third wave cognitive behavioral therapies and relational psychodynamic therapy. She currently practices CFT and incorporates the science of compassion into her work in Acceptance and Commitment Therapy, Dialectical Behavior Therapy, and exposure-based therapies as the groundwork for helping clients cultivate meaningful, values-based patterns of living.
Miranda Morris, PhDis a Peer Reviewed Trainer in Acceptance and Commitment Therapy (ACT), and she conducts regular workshops in the Mid-Atlantic region and internationally. She is a perennial student of all contextual behavioral therapies including Compassion Focused Therapy (CFT), which she integrates into her work both as a therapist and trainer. Miranda is a licensed psychologist in private practice in Bethesda, MD. She treats a broad range of difficulties including anxiety, depression, trauma, relationship problems, and pervasive difficulties often referred to as “personality disorders”. Shecurrently serves on the Board of the Association of Contextual Behavioral Science (ACBS) and is President Emeritus of the Mid-Atlantic chapter of ACBS.
Severe Irritability in Youth | 3 Category 1 CEUs*
Melissa A. Brotman, Phd
Friday, September 20, 9:15 AM-12:30 PM
National 4H Conference Center
7100 Connecticut Avenue
Chevy Chase, MD 20815
Register for all events here.
Severe irritability is one of the most common reasons that children present for mental health care; however, few effective treatments are available. Developing targeted, mechanism-based interventions is particularly essential given the new DSM-5 diagnosis of Disruptive Mood Dysregulation Disorder (DMDD). To address this pressing public health need, this presentation will describe a translational neuroscience model of irritability that operationalizes the clinical phenotype and guides the development of novel interventions (Brotman et al., 2017). In this model, pathological irritability is conceptualized as aberrant emotional and behavioral responding to frustrative nonreward and threat. This conceptualization provides tractable pathophysiological treatment targets, emerging directly from imaging studies. Specifically, the circuitry mediating frustration and threat involves perturbations in the prefrontal cortex, striatum, and amygdala. Based on this pathophysiological work, two novel treatments have been developed: an exposure-based cognitive behavioral therapy and a computer-based interpretation bias training. The treatments will be described and preliminary efficacy data from both studies will be presented.
- Define irritability and the clinical presentation of Disruptive Mood Dysregulation Disorder (DMDD) in youth.
- Identify pathophysiological markers associated with irritability.
- Discuss novel mechanism-based treatments for irritability in children and adolescents
- Present ways to leverage technology (e.g., mobile based applications) to gather clinical information
Dr. Melissa A. Brotman is the Director of the Neuroscience and Novel Therapeutics Unit in the Emotion and Development Branch at the National Institute of Mental Health (NIMH). Dr. Brotman received her Ph.D. in clinical psychology from the University of Pennsylvania, where she specialized in cognitive behavioral therapy for mood and anxiety disorders. After completing her clinical internship at the Veterans Affairs Maryland Health Care System/University of Maryland-Baltimore, she completed post-doctoral training in neuroscience at NIMH, focusing on functional magnetic resonance imaging (fMRI) and clinical phenotyping of severe irritability in youth. Currently, she uses affective neuroscience techniques to understand the brain-based mechanisms underlying severe irritability in youth, and leverages pathophysiological knowledge to guide the development of novel targeted interventions.
Ramaris E. German, PhD, is a psychologist in the Neuroscience and Novel Therapeutics Unit under the Emotion and Development Branch at the National Institute of Mental Health (NIMH). She has a broad range of clinical, research, and training experience working with children, families, and adults through her work at the University of Pennsylvania, American University, NYU-Bellevue Hospital Center, Washington DC VA Medical Center, Greenbelt Cares, and Neuropsychological Associates of Fairfax. Her research has focused on specific processes in mood disorders and in psychotherapy process and outcome as well as in the dissemination of evidence-based practices. Before joining NIMH, Dr. German worked training community mental health therapists in CBT (in English and Spanish) to increase access to quality mental health services for underserved communities through a partnership between the Philadelphia Department of Behavioral Health and the University of Pennsylvania. Dr. German is currently a psychologist researching with Dr. Melissa Brotman brain-based mechanisms underlying severe irritability in youth to develop novel targeted interventions.
Cannabis Issues in the Treatment of Young Adults | 2 Category I CEUs
Friday, October 4, 2019, 9:15 AM-11:15 PM
George Kolodner, MD
Rathbone & Associates
4701 Sangamore Road #210-N
Bethesda, MD 20816
Register for all events here.
The liberalization of state laws regarding cannabis has created increased interest in the recreational, medical, and problem use of this ancient and complex substance. Because marijuana remains illegal on a Federal level, research is impeded resulting in less than optimal understanding of the benefits and dangers. This presentation attempts to present validated information and come to a balanced judgment about the effect of the substance. particularly in regard to young adults.
- Provide information about the biology of cannabis and its impact on the body
- Describe current cannabis use trends in young adults
- Review the range of clinical problems relating to cannabis use
- Trace the evolution of cannabis policy in the U.S.
- Provide interactive opportunity to address clinician concerns and questions.
About the Presenter
Dr. George Kolodner is a board certified addiction psychiatrist who specializes in the intensive outpatient (IOP) treatment of substance use disorders. He founded Kolmac Outpatient Recovery Centers in 1973. Today, he serves as the chief innovation officer. He works to increase awareness of IOP treatment and keep Kolmac on the cusp of leading-edge treatment.
While serving as a staff psychiatrist for the U.S. Navy, he witnessed recovery from alcoholism for the first time at a Naval residential rehabilitation program. Motivated by this experience, he became interested in replicating this success in a non-residential “outpatient” setting. After leaving the Navy in 1973, he designed and implemented the first intensive outpatient (“IOP”) addiction treatment program in the country – Kolmac Outpatient Recovery Centers. His primary focus there has been on developing outpatient treatment strategies for managing withdrawal and rehabilitation services for people with substance use disorders.
Dr. Kolodner received his M.D. from the University of Rochester and completed his psychiatric training at Yale University. He has made many presentations on addictions at the annual meetings of the American Society of Addiction Medicine and the American Psychiatric Association, of which he is a Distinguished Life Fellow. His publications on addictions include articles on co-occurring psychiatric disorders, cannabis, and book chapters on outpatient withdrawal management. He is a past member of the APA Addiction Council and Addiction Treatment Committee and a current Clinical Professor of Psychiatry at both the Georgetown University School of Medicine and the University of Maryland School of Medicine.
Anxiety and Sensory Dysregulation: Diagnosis and Treatment | 3 Category 1 CEUs*
Ruth Goldfinger Golomb, LCPC
Friday, November 15, 9:15AM-12:30 PM
4701 Sangamore Road, 210-N, Bethesda, MD 20816
Register for all events here.
Anxiety Disorders and Sensory Dysregulation affect millions people world-wide. Millions of people are treated every day for anxiety disorders. Anxiety disorders are the most common illness in the United States effecting 40 million people over the age of 18 years old. There is a lifetime prevalence for children developing an anxiety disorder is 25.1%. Sensory Dysregulation is a very common less understood disorder which affects millions of people. Left untreated, children with Anxiety Disorders and Sensory Dysregulation can develop extremely complicated, hard to treat disorders in adulthood, thus, putting a strain on the workforce due to an inability to work or complete and put a drain on the healthcare system. This workshop will provide an overview of Sensory Dysregulation and identify how it affects behavior across the lifespan. Participants will learn how to identify Sensory Dysregulation as a co-morbid condition with anxiety disorders and how to effectively modify treatment in order to adequately address both conditions. Attention will be placed on childhood disorders, however we will address the issue of treating adults.
Objectives: 1.Attendees will become familiar with basic functions of the nervous system. 2. Attendees will understand the multiple ways in which Sensory Dysregulation may affect behavior. 3. Attendees will become familiar with the transdiagnostic nature of Sensory Dysregulation and how it interacts with OCD and other Anxiety Disorders. 4. Attendees will learn how to effectively modify treatment in order to adequately address the co-morbid conditions. About the Presenter Ruth Goldfinger Golomb, LCPC, is a senior clinician, supervisor, and a co-director of the training program at the Behavior Therapy Center of Greater Washington, where she has worked since the mid 1980’s. Ms. Golomb specializes in treatment of anxiety disorders in children and adults. She has conducted numerous workshops and seminars and participated as an expert in panel discussions covering many topics including Tourette Syndrome, Obsessive Compulsive Disorder, Trichotillomania, and providing cognitive behavior therapy (CBT) for anxious adults. In addition to publishing articles for professional journals and newsletters, Ms Golomb is an author of “The Hair Pulling ‘Habit’ and You: How to Solve the Trichotillomania Puzzle” a book describing the comprehensive treatment of trichotillomania in children and “Stay Out of My Hair” and “A Parent Guide to Hair Pulling Disorder: Effective Parenting Strategies for Children with Trichotillomania,” books designed to educate, guide, and support parents of children with trichotillomania. Ms Golomb is also an author of “Psychological Interventions for Children with Sensory Dysregulation.” She is a member of the Scientific Advisory Board for The TLC Foundation for BFRBs
*Continuing Education Information
Rathbone & Associates is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs and maintains full responsibility for the programs and their content. These trainings qualify for Category I continuing education units. Please contact your state board for verification of reciprocity with other states and professions. In order to receive a certificate, registrants must attend the entire session.